These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31560734)

  • 1. The Efficacy of Botulinum Toxin in Cluster Headache: A Systematic Review.
    Freund B; Kotchetkov IS; Rao A
    J Oral Facial Pain Headache; 2020; 34(2):129–134. PubMed ID: 31560734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Botulinum Toxin in Tension-Type Headaches: A Systematic Review of the Literature.
    Freund B; Rao A
    Pain Pract; 2019 Jun; 19(5):541-551. PubMed ID: 30742360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic cluster headache.
    Bratbak DF; Nordgård S; Stovner LJ; Linde M; Folvik M; Bugten V; Tronvik E
    Cephalalgia; 2016 May; 36(6):503-9. PubMed ID: 26232105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profile of botulinum toxin A in patients with chronic headaches and cervical dystonia: a prospective, open-label, longitudinal study conducted in a naturalistic clinical practice setting.
    Dowson AJ; Kilminster SG; Salt R
    Drugs R D; 2008; 9(3):147-58. PubMed ID: 18457467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-Label, Multi-Dose, Pilot Safety Study of Injection of OnabotulinumtoxinA Toward the Otic Ganglion for the Treatment of Intractable Chronic Cluster Headache.
    Crespi J; Bratbak D; Dodick DW; Matharu M; Solheim O; Gulati S; Berntsen EM; Tronvik E
    Headache; 2020 Sep; 60(8):1632-1643. PubMed ID: 32583902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Efficacy of Botulinum Toxin in Pediatric Chronic Migraine: A Literature Review.
    Marcelo R; Freund B
    J Child Neurol; 2020 Oct; 35(12):844-851. PubMed ID: 32580690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcome of Patients With Intractable Chronic Cluster Headache Treated With Injection of Onabotulinum Toxin A Toward the Sphenopalatine Ganglion - An Observational Study.
    Aschehoug I; Bratbak DF; Tronvik EA
    Headache; 2018 Nov; 58(10):1519-1529. PubMed ID: 30216444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanistic, utilization, and cost outcomes associated with the use of botulinum toxin for treatment of refractory migraine headaches in a managed care organization.
    Mitchell MP; Schaecher K; Cannon HE; Speckman M
    J Manag Care Pharm; 2008 Jun; 14(5):442-50. PubMed ID: 18597573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of botulinum toxins for chronic headaches: a focused review.
    Loder E; Biondi D
    Clin J Pain; 2002; 18(6 Suppl):S169-76. PubMed ID: 12569965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache.
    Ahmed K; Oas KH; Mack KJ; Garza I
    Pediatr Neurol; 2010 Nov; 43(5):316-9. PubMed ID: 20933173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe, intractable headache after injection with botulinum a exotoxin: report of 5 cases.
    Alam M; Arndt KA; Dover JS
    J Am Acad Dermatol; 2002 Jan; 46(1):62-5. PubMed ID: 11756947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?
    Freitag FG
    CNS Drugs; 2003; 17(6):373-81. PubMed ID: 12696998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
    Jackson JL; Kuriyama A; Hayashino Y
    JAMA; 2012 Apr; 307(16):1736-45. PubMed ID: 22535858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C;
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
    Blumenfeld A
    Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic daily headache with comorbid anxiety and depression using botulinum toxin A: a prospective pilot study.
    Zhang H; Zhang H; Wei Y; Lian Y; Chen Y; Zheng Y
    Int J Neurosci; 2017 Apr; 127(4):285-290. PubMed ID: 27439999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.
    Dodick DW
    Headache; 2003; 43 Suppl 1():S25-33. PubMed ID: 12887391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based medicine: botulinum toxin A in migraine and tension-type headache.
    Göbel H; Heinze A; Heinze-Kuhn K; Jost WH
    J Neurol; 2001 Apr; 248 Suppl 1():34-8. PubMed ID: 11357239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.